FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/03/2025
Voltar para busca
Dado oficial do USPTO
V
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 39, 42
Data de depósito
21/02/2023
Data de registro
24/09/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/09/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
DE
Examinador
MARTIN, JENNIFER MCGARRY
Unidade examinadora
M70
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized letter "V" in blue and a blue circle above the "V".
Titulares e representantes
Titulares
Vetter Pharma-Fertigung GmbH & Co. KG
Representantes
M. Scott Alprin Alprin Law Offices, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 39Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and medicines for the prevention of infectionscancerdepressionheart diseasevascular diseaseintestinal disorderlung and bronchial disfunctionliver disfunctionoral and laryngeal diseaseoptical and cranial disorders; solutions to be taken orallysterile solutions and injection solutions for medical purpose for treatment of infectionscancerdepressionheart diseasevascular diseaseintestinal disorderlung and bronchial disfunctionliver disfunctionoral and laryngeal diseaseoptical and cranial disorders; eyedropscontact lens solutions; swabs for medical purposes; plastersmaterials for dressingsmedical plasters; filled medical injection systemsfor treatment of infectionscancerdepressionheart diseasevascular diseaseintestinal disorderlung and bronchial disfunctionliver disfunctionoral and laryngeal diseaseoptical and cranial dis-orders in particular syringes and instruments for injectionsinjectorsauto-injectors and single-chamber and dual-chamber disposable syringes; packaging units packaged individually or in combination with one another for medical and medical technology purposespackaging units containing prefilled prepared syringesdisposable syringesdisposable cannulaeampoules and medicine vials for treatment of infectionscancerdepressionheart diseasevascular diseaseintestinal disorderlung and bronchial disfunctionliver disfunctionoral and laryngeal diseaseoptical and cranial disorders
Classe 10
Empty medical injection apparatussyringes for injectionsinjectorsauto-injectors and single-chamber and dual-chamber disposable syringes; medicine instruments in the form of containers for administering medicinesmedical vialssyringesmedical cartridges and medical dual-chamber vials and syringes of glass or plastic; holders specially adapted for syringes
Classe 39
Bottling of liquid and solid substancesin particular of pharmaceuticalsmedicines and solutionsfor others
Classe 42
Pharmaceutical drug development servicesdevelopment of syringes and instruments for injectionsinjectors and packaging for the aforesaid goodsfor others; chemicalphysical and process engineering testsin particular laboratory testsengineering material testingengineering product testingengineering quality testing for manufacturing processes; development and conducting of pharmacological and microbiological tests and processesincluding for otherstesting of pharmaceuticals and pharmaceutical drug development services
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/03/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/03/2025
FIMP
FINAL DISPOSITION PROCESSED
03/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/02/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
20/02/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/12/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
24/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2024
PUBO
PUBLISHED FOR OPPOSITION
09/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/05/2024
RFNT
REFUSAL PROCESSED BY IB
19/12/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/11/2023
RFRR
REFUSAL PROCESSED BY MPU
30/11/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/11/2023
CNRT
NON-FINAL ACTION WRITTEN
28/11/2023
DOCK
ASSIGNED TO EXAMINER
20/11/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/11/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/11/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/11/2023
MAFR
APPLICATION FILING RECEIPT MAILED
26/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/09/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/09/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace V ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.